DE60045707D1 - Somatische transgene immunisierung und darauf bezogene verfahren - Google Patents

Somatische transgene immunisierung und darauf bezogene verfahren

Info

Publication number
DE60045707D1
DE60045707D1 DE60045707T DE60045707T DE60045707D1 DE 60045707 D1 DE60045707 D1 DE 60045707D1 DE 60045707 T DE60045707 T DE 60045707T DE 60045707 T DE60045707 T DE 60045707T DE 60045707 D1 DE60045707 D1 DE 60045707D1
Authority
DE
Germany
Prior art keywords
nucleic acid
hematopoietic cell
acid molecule
sequence encoding
specific expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60045707T
Other languages
German (de)
English (en)
Inventor
Maurizio Zanetti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nevagen LLC
Original Assignee
Nevagen LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23161331&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60045707(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US09/300,959 external-priority patent/US7279462B1/en
Application filed by Nevagen LLC filed Critical Nevagen LLC
Application granted granted Critical
Publication of DE60045707D1 publication Critical patent/DE60045707D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70514—CD4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70517—CD8
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/74—Inducing cell proliferation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Biological Depolymerization Polymers (AREA)
DE60045707T 1999-04-27 2000-04-27 Somatische transgene immunisierung und darauf bezogene verfahren Expired - Lifetime DE60045707D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/300,959 US7279462B1 (en) 1998-04-27 1999-04-27 Somatic transgene immunization and related methods
PCT/US2000/011372 WO2000064488A2 (en) 1999-04-27 2000-04-27 Somatic transgene immunization and related methods

Publications (1)

Publication Number Publication Date
DE60045707D1 true DE60045707D1 (de) 2011-04-21

Family

ID=23161331

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60045707T Expired - Lifetime DE60045707D1 (de) 1999-04-27 2000-04-27 Somatische transgene immunisierung und darauf bezogene verfahren

Country Status (7)

Country Link
US (1) US20080076175A1 (enExample)
EP (1) EP1181320B1 (enExample)
JP (2) JP5000807B2 (enExample)
AT (1) ATE501175T1 (enExample)
CA (1) CA2369616C (enExample)
DE (1) DE60045707D1 (enExample)
WO (1) WO2000064488A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7279462B1 (en) 1998-04-27 2007-10-09 Nevagen Llc Somatic transgene immunization and related methods
GB0102145D0 (en) 2001-01-26 2001-03-14 Scancell Ltd Substances
EP1887084A1 (en) * 2006-08-10 2008-02-13 International Investment and Patents SA Plasmids with immunological action
GB0706070D0 (en) 2007-03-28 2007-05-09 Scancell Ltd Nucleic acids
JOP20190271A1 (ar) * 2017-05-24 2019-11-21 Novartis Ag بروتينات مطعّمة بسيتوكين- الجسم المضاد وطرق الاستخدام للاضطرابات المتعلقة بالمناعة

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69023900D1 (de) * 1989-02-24 1996-01-11 Univ California Gentechnologisch veränderte immunglobuline.
US5703055A (en) * 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5969109A (en) * 1990-02-28 1999-10-19 Bona; Constantin Chimeric antibodies comprising antigen binding sites and B and T cell epitopes
US6977074B2 (en) * 1997-07-10 2005-12-20 Mannkind Corporation Method of inducing a CTL response
US5891432A (en) * 1997-07-29 1999-04-06 The Immune Response Corporation Membrane-bound cytokine compositions comprising GM=CSF and methods of modulating an immune response using same
US7279462B1 (en) * 1998-04-27 2007-10-09 Nevagen Llc Somatic transgene immunization and related methods
US6306640B1 (en) * 1998-10-05 2001-10-23 Genzyme Corporation Melanoma antigenic peptides

Also Published As

Publication number Publication date
JP5000807B2 (ja) 2012-08-15
WO2000064488A2 (en) 2000-11-02
JP2002542305A (ja) 2002-12-10
EP1181320B1 (en) 2011-03-09
WO2000064488A3 (en) 2001-05-10
CA2369616C (en) 2009-09-15
ATE501175T1 (de) 2011-03-15
US20080076175A1 (en) 2008-03-27
WO2000064488A9 (en) 2002-07-11
JP2009102369A (ja) 2009-05-14
CA2369616A1 (en) 2000-11-02
EP1181320A2 (en) 2002-02-27

Similar Documents

Publication Publication Date Title
ES2555979T3 (es) Anticuerpos monoclonales contra la claudina-18 para el tratamiento del cáncer
EA007958B1 (ru) ТРАНСГЕННЫЙ ВЕКТОР, СОДЕРЖАЩИЙ ГУМАНИЗИРОВАННЫЙ ЛОКУС Ig, И ЕГО ПРИМЕНЕНИЕ ДЛЯ ПОЛУЧЕНИЯ ТРАНСГЕННЫХ ЖИВОТНЫХ
JP3484442B2 (ja) トランスジェニック動物からの抗体の生産
ES2144424T5 (es) Vacuna que comprende parte de la region constante de ige para el tratamiento de reacciones alergicas inducidas por ige.
US20080299112A1 (en) Human Polyclonal Antibodies from Genetically Engineered Animals
BR0013542A (pt) Moléculas b7-4 e usos para as mesmas
DK0680513T3 (da) Målretning af immunogener med lysosomer
FI105452B (fi) Idiotyyppirokotuksen valmistus B-solulymfoomaa vastaan
DE69533964D1 (de) Orale immunisierung durch verwendung von transgenen pflanzen
ATE342282T1 (de) Humane monoklonale antikörper gegen prostata spezifisches membranantigen
ATE444361T1 (de) Il-17 und il-17r homologe polypeptide und deren therapeutische verwendungen
ATE512231T1 (de) Impfstoffe, immuntherapeutika und verfahren zur anwendung derselben
BRPI0214168B8 (pt) anticorpos anti-il-6, moléculas de ácido nucleico codificando os mesmos, vetores compreendendo as referidas moléculas, composições e formulações compreendendo os referidos anticorpos, bem como métodos de produção dos mesmos
JPH04504424A (ja) 膜結合ＩｇＡに存在するが分泌ＩｇＡに存在しない抗原エピトープ
ATE366814T1 (de) Gl50 moleküle, sowie verwendungen derselben
US20220364125A1 (en) Genome engineering the human immunoglobulin locus to express recombinant binding domain molecules
BR0010155A (pt) Proteìnas isolada, e quimérica, composição, molécula de ácido nucleico, plasmìdeo, vacina recombinante ou vacina atenuada, composição de vacina recombinante ou composição de vacina atenuada, composição farmacêutica, métodos de imunizar um indivìduo contra um imunógeno, proteìna não-cd80 isolada, molécula de ácido nucleico, e, método de imunossuprimir um indivìduo
ATE501175T1 (de) Somatische transgene immunisierung und darauf bezogene verfahren
Roberts et al. The cloning and expression of an anti-peptide antibody: a system for rapid analysis of the binding properties of engineered antibodies
DE60140559D1 (de) 32144, eine humane fettsäureamid-hydrolase und deren verwendungen
ATE480620T1 (de) Neue pgc-1-isoformen und deren verwendungen
Bazin et al. Louvain rat immunocytomas
Nagel et al. Studies on Tetanus Antitoxins: II. Demonstration of at Least Four Antitoxins of Different Specificity in Antitoxic Sera
Hastings et al. Production and characterization of a murine/human chimeric anti-idiotype antibody that mimics ganglioside
Pluschke et al. Generation of chimeric monoclonal antibodies from mice that carry human immunoglobulin Cγ1 heavy or Cκ light chain gene segments